Trial intelligence / Profile preview

Influence of sodium cromoglicate on EVH test in young elite athletes with exercise-induced bronchoconstriction

2019-003606-27Phase 3Completed

Sponsor
Uz
Start
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of sodium cromoglycate in exercise-induced bronchospasm (EIB) (2 arms), sponsored by Uz. Primary endpoint: Change in maximal fall in FEV1 on EVH test. Started Feb 2020; status: completed.

02

Drugs

sodium cromoglycate
03

Conditions

exercise-induced bronchospasm (EIB)

Beyond the preview

Go deeper on 2019-003606-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-003606-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call